Category · Metabolic

Metabolic & Weight Loss Peptides.

GLP-1, GIP, and metabolic compounds researched for appetite, body composition, and fat-loss support.

6 compounds tracked

Tier Bmed-high risk

AOD-9604

hGH fragment 176-191 · GH hexadecapeptide

GH fragment studied in human obesity trials for lipolytic effects via β-adrenergic pathways.

View profile

Tier Chigh risk

MOTS-c

Mitochondrial-derived peptide

Mitochondrial-derived peptide studied in mouse models for metabolic homeostasis and insulin sensitivity.

View profile

Tier Amedium risk

Semaglutide

Ozempic · Wegovy

FDA-approved GLP-1 receptor agonist with strong human data for diabetes and obesity management.

View profile

Tier Amedium risk

Tirzepatide

Mounjaro · Zepbound

Dual GIP/GLP-1 agonist with strong FDA-approved human data for glycemic control and weight loss.

View profile

Tier Amedium risk

Liraglutide

Victoza · Saxenda

Once-daily GLP-1 receptor agonist with extensive clinical data for diabetes and obesity care.

View profile

Tier Cmed-high risk

Retatrutide

LY3437943 · triple incretin agonist

Investigational triple-agonist obesity drug candidate with early human weight-loss data but no approval.

View profile

All categories

Tissue Repair Growth Hormone Melanocortin Neuroprotection Sleep Reproductive Longevity Immune Skin Antimicrobial Cognitive Mitochondrial Growth Factor Muscle Repair

Personalized peptide routing

Find the right path for Metabolic.

Take the quiz before choosing a compound, vendor, or PDF. We match your goal, experience, budget, and monitoring comfort to the next best step in the funnel.

Goal-matched compound and protocol recommendations.
Budget and sourcing filters before you leave the site.
PDF unlocks shown after your personalized result.

Take the quiz